Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic study of test-dose 5-fluorouracil in colorectal cancer patients (5-FLUORO TEST)
2007-003831-21Phase 4Active
- Sponsor
- Azienda Ospedaliero-Universitaria Pisana
- Start
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of fluorouracil in colorectal cancer (CRC) and colorectal adenocarcinoma, sponsored by Azienda Ospedaliero-Universitaria Pisana. Primary endpoints: Pharmacokinetic parameters of 5-FU and 5-FDHU and Identification of pharmacokinetic toxicity indicators. Started Oct 2007; status: active.
02
Drugs
fluorouracil
03
Conditions
colorectal cancer (CRC)colorectal adenocarcinoma
Beyond the preview
Go deeper on 2007-003831-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003831-21.